FREE Account Opening + No Clearing Fees
Loading...

Brainbees Solutions (Firstcry) IPO vs Emcure Pharma IPO

Comparision between Brainbees Solutions (Firstcry) IPO and Emcure Pharma IPO.

IPO Details

Brainbees Solutions (Firstcry) IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Brainbees Solutions (Firstcry) IPO is up to ₹4,193.73 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Brainbees Solutions (Firstcry) IPO is ₹465.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

  Brainbees Solutions (Firstcry) IPO Emcure Pharma IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹440.00 per share ₹960.00 per share
Issue Price (Upper) ₹465.00 per share ₹1,008.00 per share
Issue Price (Final) ₹465.00 per share ₹1,008.00 per share
Discount (Retail)
Discount (Employee) ₹44.00 per share ₹90.00 per share
Market Lot Size 32 shares 14 shares
Fresh Issue Size 3,58,27,957 shares 79,36,507 shares
Fresh Issue Size (Amount) up to ₹1,666.00 Cr up to ₹800.00 Cr
OFS Issue Size 5,43,59,733 shares 1,14,28,839 shares
OFS Issue Size (Amount) up to ₹2,527.73 Cr up to ₹1,152.03 Cr
Issue Size Total 9,01,87,690 shares 1,93,65,346 shares
Issue Size Total (Amount) up to ₹4,193.73 Cr up to ₹1,952.03 Cr

IPO Timetable

Brainbees Solutions (Firstcry) IPO opens on Aug 06, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Brainbees Solutions (Firstcry) IPO and Emcure Pharma IPO is Aug 08, 2024, and Jul 05, 2024, respectively.

  Brainbees Solutions (Firstcry) IPO Emcure Pharma IPO
Anchor Bid Date Aug 05, 2024 Jul 02, 2024
Issue Open Aug 06, 2024 Jul 03, 2024
Issue Close Aug 08, 2024 Jul 05, 2024
Basis Of Allotment (Tentative) Aug 09, 2024 Jul 08, 2024
Initiation of Refunds (Tentative) Aug 12, 2024 Jul 09, 2024
Credit of Share (Tentative) Aug 12, 2024 Jul 09, 2024
Listing date (Tentative) Aug 13, 2024 Jul 10, 2024
Anchor Lockin End date 1 Sep 08, 2024 Aug 07, 2024
Anchor Lockin End date 2 Nov 07, 2024 Oct 06, 2024

Financials

Brainbees Solutions (Firstcry) IPO P/E ratio is -69.91, as compared to Emcure Pharma IPO P/E ratio of 34.55.

  Brainbees Solutions (Firstcry) IPO Emcure Pharma IPO
Financial

Brainbees Solutions Limited Financial Information (Restated Consolidated)

Brainbees Solutions Limited's revenue increased by 14.72% and profit after tax (PAT) rose by 33.85% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets7,510.387,119.836,197.16
Revenue6,575.085,731.282,516.92
Profit After Tax-321.51-486.06-78.69
Net Worth3,170.743,456.263,527.94
Reserves and Surplus3,081.743,367.213,439.17
Total Borrowing462.72176.4790.16
Amount in ₹ Crore

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets7,806.166,672.536,063.47
Revenue6,715.246,031.725,918.86
Profit After Tax527.58561.85702.56
Net Worth2,952.282,501.131,987.55
Reserves and Surplus2,722.402,293.771,791.03
Total Borrowing2,091.942,202.422,102.19
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 98.90%
Promoter Shareholding (Post-Issue) 78.24%
P/E Ratio -69.91 34.55
Market Cap ₹24141.75 Cr. ₹19029.89 Cr.
ROE 16.90%%
ROCE 19.37%%
Debt/Equity 0.67
EPS ₹-6.65 ₹29.17
RoNW -8.65%% 16.87%%

Shares Offered

In the Brainbees Solutions (Firstcry) IPO retail investors (RII) are offered 90,12,317 shares while in Emcure Pharma IPO retail investors are offered 90,12,317 shares. Qualified institutional buyers (QIB) are offered 2,70,36,953 shares in Brainbees Solutions (Firstcry) IPO and 38,53,234 shares in Emcure Pharma IPO.

  Brainbees Solutions (Firstcry) IPO Emcure Pharma IPO
Anchor Investor Reserveration 4,05,55,428 shares 57,79,850 shares
Market Maker Reserveration
QIB 2,70,36,953 shares 38,53,234 shares
NII 1,35,18,476 shares 28,89,926 shares
RII 90,12,317 shares 67,43,160 shares
Employee 71,258 shares 1,08,900 shares
Others
Total 4,96,39,004 shares 1,37,03,538 shares

Bids Received (Subscription)

Brainbees Solutions (Firstcry) IPO subscribed 12.22x in total, whereas Emcure Pharma IPO subscribed 67.87x.

  Brainbees Solutions (Firstcry) IPO Emcure Pharma IPO
QIB (times) 19.30x 191.24x
NII (times) 4.68x 49.32x
Big NII (times) 5.32x 54.90x
Small NII (times) 3.39x 38.16x
RII (times) 2.31x 7.36x
Employee (times) 6.57x 8.81x
Other (times)
Total (times) 12.22x 67.87x

Comments

Add a public comment...